EUVIMEDOpdag EUVIMED
Open access

Multi‐target effects of Limosilactobacillus reuteri RE225 on hyperuricemia through xanthine oxidase inhibition, nucleoside degradation, gut microbiota modulation, and renal TLR4 ‐ NF ‐ κ B suppression

Xin Zhou, Ming Zhang, Jun Zhou, Jiaojiao Han iD

Journal of the Science of Food and Agriculture · 2026-09 · 106 (12) · 7197-7208

DOI: 10.1002/jsfa.70749 ↗

At a glance

Journal article in Journal of the Science of Food and Agriculture, published online on 2026-05-28. Written by Xin Zhou and 3 co-authors. Institution: State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, School of Marine Sciences, Ningbo Universit…. Major MEDLINE topics: NF-kappa B, Xanthine Oxidase, Toll-Like Receptor 4, Kidney. Cited 3 times so far (Crossref); 49 references. The full text is freely available in PubMed Central. Funded by: Ningbo Public Welfare Research Program, K.C. Wong Magna Fund of Ningbo University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND Hyperuricemia, a major risk factor for gout and kidney disease, requires safe and effective dietary strategies beyond conventional pharmacotherapy. This study investigated the multi‐target effects of the food‐grade probiotic Limosilactobacillus reuteri RE225 on hyperuricemia. It was evaluated in vitro for xanthine oxidase (XOD) inhibition and nucleoside degradation, and in vivo in hyperuricemic mice gavaged daily with low or high doses of RE225 (1 × 10 6 or 1 × 10 9 CFU). Serum uric acid (UA), XOD activity, inflammatory cytokines, intestinal permeability markers – fluorescein isothiocyanate–dextran (FITC‐dextran), lipopolysaccharide (LPS), and d ‐lactate – and renal TLR4/NF‐ κ B signaling were quantified. Fecal metagenomics and Kyoto Encyclopedia of Genes and Genomes ortholog (KO) profiling were used to assess microbiota structure and function. RESULTS Limosilactobacillus reuteri RE225 dose‐dependently inhibited XOD and degraded more than 50% of nucleosides in vitro . In vivo , RE225 reduced serum urate, restored intestinal barrier function, suppressed inflammation, and downregulated renal TLR4/NF‐ κ B signaling. Metagenomic analysis showed that L. reuteri RE225 reversed UA‐induced loss of microbial richness and evenness, enriched Faecalibaculum and Erysipelotrichaceae , and shifted functional profiles from proliferation‐ and inflammation‐related modules (K02315, K02970, and K03496) toward carbohydrate utilization and genetic stability pathways (K01784 and K07491). CONCLUSION Limosilactobacillus reuteri RE225 shows promise as a dietary intervention for the management of hyperuricemia. © 2026 Society of Chemical Industry.

Subjects

MeSH terms (MEDLINE)

NF-kappa BXanthine OxidaseToll-Like Receptor 4KidneyHyperuricemiaGastrointestinal MicrobiomeLimosilactobacillus reuteriProbioticsAnimalsMiceMaleUric AcidHumansMice, Inbred C57BLBacteriaSignal Transduction

Author keywords

Limosilactobacillus reuteri RE225TLR4/NF‐κB pathwaygut microbiota remodelinghyperuricemiaxanthine oxidase inhibition

Substances

NF-kappa BXanthine OxidaseToll-Like Receptor 4Uric Acid

Authors and institutions

  • State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, School of Marine Sciences, Ningbo University, Ningbo, China.

ORCID profiles: Jiaojiao Han

Funding

  • Ningbo Public Welfare Research Program
  • K.C. Wong Magna Fund of Ningbo University

Cite

APA

Zhou, X., Zhang, M., Zhou, J., & Han, J. (2026). Multi‐target effects of Limosilactobacillus reuteri RE225 on hyperuricemia through xanthine oxidase inhibition, nucleoside degradation, gut microbiota modulation, and renal TLR4 ‐ NF ‐ κ B suppression. Journal of the Science of Food and Agriculture, 106(12), 7197-7208. https://doi.org/10.1002/jsfa.70749

Vancouver

Zhou X, Zhang M, Zhou J, Han J. Multi‐target effects of Limosilactobacillus reuteri RE225 on hyperuricemia through xanthine oxidase inhibition, nucleoside degradation, gut microbiota modulation, and renal TLR4 ‐ NF ‐ κ B suppression. Journal of the Science of Food and Agriculture. 2026;106(12):7197-7208. doi:10.1002/jsfa.70749

BibTeX
@article{Zhou2026,
  author = {Zhou, Xin and Zhang, Ming and Zhou, Jun and Han, Jiaojiao},
  title = {Multi‐target effects of Limosilactobacillus reuteri RE225 on hyperuricemia through xanthine oxidase inhibition, nucleoside degradation, gut microbiota modulation, and renal TLR4 ‐ NF ‐ κ B suppression},
  journal = {Journal of the Science of Food and Agriculture},
  year = {2026},
  volume = {106},
  number = {12},
  pages = {7197--7208},
  doi = {10.1002/jsfa.70749}
}
Start for free →